Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5867413 | 1.00 | GGT1 (0.41) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL474688 | 1.00 | GGT1 (0.41) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL5904142 | 0.91 | GGT1 (0.36) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL3386652 | 0.89 | NOD1 (0.49) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL3386644 | 0.89 | NOD1 (0.49) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL8627016 | 0.87 | GGT1 (0.46) | GGT1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL3260932 | 0.87 | NOD1 (0.51) | GGT1MAPTSMN1; SMN2NOD1FOLH1 | |
| SCHEMBL11162391 | 0.87 | NOD1 (0.51) | GGT1MAPTSMN1; SMN2NOD1FOLH1 | |
| SCHEMBL3260935 | 0.87 | NOD1 (0.51) | GGT1MAPTSMN1; SMN2NOD1FOLH1 | |
| SCHEMBL10630157 | 0.85 | NOD1 (0.53) | MAPTNOD1ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018128826-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-07-12 | — | — | WO | claimed |
| WO-2018006063-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-01-04 | — | — | WO | claimed |
| EP-2411360-A1 | RADIOLABELED FLUORINE DERIVATIVES OF METHIONINE | CRC For Biomedical Imaging Development Ltd (AU) | 2012-02-01 | — | — | EP | claimed |
| WO-2010108210-A1 | RADIOLABELED FLUORINE DERIVATIVES OF METHIONINE | CRC FOR BIOMEDICAL IMAGING DEVELOPMENT LTD (AU) | 2010-09-30 | — | — | WO | claimed |
| EP-1379214-A1 | HAIR RELAXER COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE ACTIVATING AGENT, AND METHODS OF USING SAME | L'OREAL, S.A. (FR) | 2004-01-14 | — | — | EP | claimed |
| US-20020159962-A1 | Hair relaxer compositions comprising at least one hydroxide compound and at least one activating agent, and methods of using the same | L'OREAL S.A. (FR) | 2002-10-31 | — | — | US | claimed |
| WO-2002067875-A1 | HAIR RELAXER COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE ACTIVATING AGENT, AND METHODS OF USING THE SAME | L'OREAL S.A. (FR) | 2002-09-06 | — | — | WO | claimed |
| WO-2018128826-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-07-12 | — | — | WO | disclosed |
| WO-2018006063-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2018-01-04 | — | — | WO | disclosed |
| US-9803180-B2 | S-adenosylmethionine (SAM) synthase variants for the synthesis of artificial cofactors | Leibniz-Institut für Pflanzenbiochemie Stiftung des öffentlichen Rechts (DE) | 2017-10-31 | — | — | US | disclosed |
| US-20170240870-A9 | S-ADENOSYLMETHIONINE (SAM) SYNTHASE VARIANTS FOR THE SYNTHESIS OF ARTIFICIAL COFACTORS | Leibniz-Institut für Pflanzenbiochemie Stiftung des öffentlichen Rechts (DE) | 2017-08-24 | — | — | US | disclosed |
| EP-3066197-B1 | S-ADENOSYLMETHIONINE (SAM) SYNTHASE VARIANTS FOR THE SYNTHESIS OF ARTIFICIAL COFACTORS | LEIBNIZ-INSTITUT FÜR PFLANZENBIOCHEMIE STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2017-08-16 | — | — | EP | disclosed |
| US-20160264946-A1 | S-ADENOSYLMETHIONINE (SAM) SYNTHASE VARIANTS FOR THE SYNTHESIS OF ARTIFICIAL COFACTORS | LEIBNIZ-INSTITUT FÜR PFLANZEN-BIOCHEMIE STIFTUNG DES ÖFFENTLICHEN RECHTS (DE) | 2016-09-15 | — | — | US | disclosed |
| US-20120093726-A1 | Radiolabeled Fluorine Derivatives of Methionine | CRC FOR BIOMEDICAL IMAGING DEVELOPMENT LTD. (AU) | 2012-04-19 | — | — | US | disclosed |
| EP-2411360-A1 | RADIOLABELED FLUORINE DERIVATIVES OF METHIONINE | CRC For Biomedical Imaging Development Ltd (AU) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010108210-A1 | RADIOLABELED FLUORINE DERIVATIVES OF METHIONINE | CRC FOR BIOMEDICAL IMAGING DEVELOPMENT LTD (AU) | 2010-09-30 | — | — | WO | disclosed |
| US-7118736-B2 | Hair relaxer compositions comprising at least one hydroxide compound and at least one activating agent, and methods of using the same | L'OREAL (FR) | 2006-10-10 | — | — | US | disclosed |
| EP-1379214-A1 | HAIR RELAXER COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE ACTIVATING AGENT, AND METHODS OF USING SAME | L'OREAL, S.A. (FR) | 2004-01-14 | — | — | EP | disclosed |
| US-20020159962-A1 | Hair relaxer compositions comprising at least one hydroxide compound and at least one activating agent, and methods of using the same | L'OREAL S.A. (FR) | 2002-10-31 | — | — | US | disclosed |
| WO-2002067875-A1 | HAIR RELAXER COMPOSITIONS COMPRISING AT LEAST ONE HYDROXIDE COMPOUND AND AT LEAST ONE ACTIVATING AGENT, AND METHODS OF USING THE SAME | L'OREAL S.A. (FR) | 2002-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120093726-A1 | Radiolabeled Fluorine Derivatives of Methionine | BHMT2, MGMT, AHCY | GGT1 251/4885KDM4E 2789/4885MAPT 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.